649 related articles for article (PubMed ID: 18056255)
41. Isolation of rat dihydrofolate reductase gene and characterization of recombinant enzyme.
Wang Y; Bruenn JA; Queener SF; Cody V
Antimicrob Agents Chemother; 2001 Sep; 45(9):2517-23. PubMed ID: 11502523
[TBL] [Abstract][Full Text] [Related]
42. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
[TBL] [Abstract][Full Text] [Related]
43. Effect of dihydrofolate reductase gene knock-down on the expression of heart and neural crest derivatives expressed transcript 2 in zebrafish cardiac development.
Sun SN; Gui YH; Wang YX; Qian LX; Jiang Q; Liu D; Song HY
Chin Med J (Engl); 2007 Jul; 120(13):1166-71. PubMed ID: 17637246
[TBL] [Abstract][Full Text] [Related]
44. Mycobacterium tuberculosis dihydrofolate reductase reveals two conformational states and a possible low affinity mechanism to antifolate drugs.
Dias MV; Tyrakis P; Domingues RR; Paes Leme AF; Blundell TL
Structure; 2014 Jan; 22(1):94-103. PubMed ID: 24210757
[TBL] [Abstract][Full Text] [Related]
45. Novel 5-substituted, 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors with antiangiogenic and antitumor activity.
Gangjee A; Zeng Y; Ihnat M; Warnke LA; Green DW; Kisliuk RL; Lin FT
Bioorg Med Chem; 2005 Sep; 13(18):5475-91. PubMed ID: 16039863
[TBL] [Abstract][Full Text] [Related]
46. Novel dihydrofolate reductase inhibitors. Structure-based versus diversity-based library design and high-throughput synthesis and screening.
Wyss PC; Gerber P; Hartman PG; Hubschwerlen C; Locher H; Marty HP; Stahl M
J Med Chem; 2003 Jun; 46(12):2304-12. PubMed ID: 12773035
[TBL] [Abstract][Full Text] [Related]
47. In vitro biological evaluation of biguanides and dihydrotriazines against Brugia malayi and folate reversal studies.
Bag S; Tawari NR; Sharma R; Goswami K; Reddy MV; Degani MS
Acta Trop; 2010 Jan; 113(1):48-51. PubMed ID: 19769933
[TBL] [Abstract][Full Text] [Related]
48. Design and synthesis of dihydrofolate reductase inhibitors encompassing a bridging ester group. Evaluation in a mouse colitis model.
Graffner-Nordberg M; Fyfe M; Brattsand R; Mellgård B; Hallberg A
J Med Chem; 2003 Jul; 46(16):3455-62. PubMed ID: 12877583
[TBL] [Abstract][Full Text] [Related]
49. Potential antifolate resistance determinants and genotypic variation in the bifunctional dihydrofolate reductase-thymidylate synthase gene from human and bovine isolates of Cryptosporidium parvum.
Vásquez JR; Goozé L; Kim K; Gut J; Petersen C; Nelson RG
Mol Biochem Parasitol; 1996 Aug; 79(2):153-65. PubMed ID: 8855552
[TBL] [Abstract][Full Text] [Related]
50. Identification of amino acids required for the functional up-regulation of human dihydrofolate reductase protein in response to antifolate Treatment.
Skacel N; Menon LG; Mishra PJ; Peters R; Banerjee D; Bertino JR; Abali EE
J Biol Chem; 2005 Jun; 280(24):22721-31. PubMed ID: 15817466
[TBL] [Abstract][Full Text] [Related]
51. Role of ionic interactions in ligand binding and catalysis of R67 dihydrofolate reductase.
Hicks SN; Smiley RD; Hamilton JB; Howell EE
Biochemistry; 2003 Sep; 42(36):10569-78. PubMed ID: 12962480
[TBL] [Abstract][Full Text] [Related]
52. Mutations leading to antifolate resistance in Chinese hamster ovary cells after exposure to the alkylating agent ethylmethanesulfonate.
Fanin R; Banerjee D; Volkenandt M; Waltham M; Li WW; Dicker AP; Schweitzer BI; Bertino JR
Mol Pharmacol; 1993 Jul; 44(1):13-21. PubMed ID: 8341268
[TBL] [Abstract][Full Text] [Related]
53. Antifolate screening using yeast expressing Plasmodium vivax dihydrofolate reductase and in vitro drug susceptibility assay for Plasmodium falciparum.
Djapa LY; Basco LK; Zelikson R; Rosowsky A; Djaman JA; Yonkeu JN; Bolotin-Fukuhara M; Mazabraud A
Mol Biochem Parasitol; 2007 Nov; 156(1):89-92. PubMed ID: 17727978
[TBL] [Abstract][Full Text] [Related]
54. Functional expression of the dihydrofolate reductase domain of Leishmania major dihydrofolate reductase-thymidylate synthase bifunctional protein.
Yu PL; Zhao J; Yu M; Reid R; Santi DV
Protein Expr Purif; 1996 Aug; 8(1):23-7. PubMed ID: 8812831
[TBL] [Abstract][Full Text] [Related]
55. Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs.
Al-Rashood ST; Aboldahab IA; Nagi MN; Abouzeid LA; Abdel-Aziz AA; Abdel-Hamide SG; Youssef KM; Al-Obaid AM; El-Subbagh HI
Bioorg Med Chem; 2006 Dec; 14(24):8608-21. PubMed ID: 16971132
[TBL] [Abstract][Full Text] [Related]
56. Expression and characterization of recombinant human-derived Pneumocystis carinii dihydrofolate reductase.
Ma L; Kovacs JA
Antimicrob Agents Chemother; 2000 Nov; 44(11):3092-6. PubMed ID: 11036028
[TBL] [Abstract][Full Text] [Related]
57. In vitro efficacy of new antifolates against trimethoprim-resistant Bacillus anthracis.
Barrow EW; Dreier J; Reinelt S; Bourne PC; Barrow WW
Antimicrob Agents Chemother; 2007 Dec; 51(12):4447-52. PubMed ID: 17875993
[TBL] [Abstract][Full Text] [Related]
58. Mechanism inspired development of rationally designed dihydrofolate reductase inhibitors as anticancer agents.
Singh P; Kaur M; Sachdeva S
J Med Chem; 2012 Jul; 55(14):6381-90. PubMed ID: 22734697
[TBL] [Abstract][Full Text] [Related]
59. Calorimetric studies of ligand binding in R67 dihydrofolate reductase.
Jackson M; Chopra S; Smiley RD; Maynord PO; Rosowsky A; London RE; Levy L; Kalman TI; Howell EE
Biochemistry; 2005 Sep; 44(37):12420-33. PubMed ID: 16156655
[TBL] [Abstract][Full Text] [Related]
60. Hydride transfer during catalysis by dihydrofolate reductase from Thermotoga maritima.
Maglia G; Javed MH; Allemann RK
Biochem J; 2003 Sep; 374(Pt 2):529-35. PubMed ID: 12765545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
